Markets & Finance

Sepracor Jumps after Medicare News


Accenture posts stronger results; First Data sees weaker earnings; plus more stocks in the news Thursday

From Standard & Poor's Equity ResearchShares of Sepracor (SEPR) moved solidly higher Thursday after Centers for Medicare and Medicaid Services announce Medicare reimbursement for Xopenex and similar respiratory

drugs will be set after national study to be completed September, 2007. S&P thinks this delays for 9 or 12 months any possible reimbursement cuts in Xopenex.

Sky Financial Group (SKYF) agrees to be acquired by Huntington Bancshares (HBAN) in a stock and cash deal valued at about $3.6 billion. Terms: 1.098 Huntington Bancshares stock (tax-free) and $3.023 cash (taxable) per Sky Financial share.

Accenture Ltd (ACN) Posts $0.46 vs. $0.36 first quarter GAAP earnings per share (EPS) on a 14% revenue rise. Raises fiscal year 2007 EPS view by $0.03 to between $1.80 and $1.85.

First Data (FDC) Sees $0.28 to $0.30 fourth quarter GAAP EPS from continuing operations and $1.06 to $1.08 in 2006. Sees $1.20 to $1.26 2007 EPS from continuing operations.

Jabil Circuit (JBL) Says first quarter net revenue rose 34% to $3.2 billion. Expects fiscal year 2007 revenue growth of approximately 20% to between $2.75 billion and $2.85 billion. Says previously reported investigation in stock options and other matters are ongoing.

General Mills (GIS) Posts $1.08 vs. $0.97 second quarter EPS on a 5% revenue rise. Raises fiscal year 2007 EPS guidance to between $3.09 and $3.13, including $0.12 stock option expense.

Nike, Inc (NKE) Posts $1.28 vs. 1.14 second quarter EPS on 10% revenue growth. Says worldwide futures orders for athletic footwear and apparel rose 7%.

Boston Scientific (BSX) CNBC announces that Cleveland Clinic has signed a 2-year contract to use stents only from Boston Scientific. CNBC says this will take from Johnson & Johnson (JNJ) market share.

Paychex Inc (PAYX) Posts $0.35 vs. $0.30 second quarter EPS on a 14% revenue rise.


Toyota's Hydrogen Man
LIMITED-TIME OFFER SUBSCRIBE NOW

Sponsored Financial Commentaries

Sponsored Links

Buy a link now!

 
blog comments powered by Disqus